文献速递产科母胎医学

绒毛膜绒毛取样(CVS)或羊膜腔穿刺(AC)是否诱导RhD免疫?对丹麦一个未常规在侵入性产前检测后给予抗D免疫球蛋白的大队列的评估

Do chorionic villus samplings (CVS) or amniocenteses (AC) induce RhD immunisation? An evaluation of a large Danish cohort with no routine administration of anti-D after invasive prenatal testing.
PubMed 文献 · BJOG · 2019-07-25

该登记研究纳入丹麦未接受抗D预防的RhD阴性孕妇共10085例,其中无侵入性操作组9353例、羊膜腔穿刺组189例、绒毛膜绒毛取样组543例;比较孕8-12周与孕25-29周两次筛查间RhD免疫发生率。结果显示无操作组和羊膜腔穿刺组均无免疫发生,绒毛膜绒毛取样组有1例免疫,与无操作组比较差异未达统计学显著(P=0.055)。

要点

  • 在未给予抗D预防的RhD阴性孕妇中,孕25-29周前RhD免疫发生率极低。
  • 羊膜腔穿刺组无RhD免疫发生,绒毛膜绒毛取样组有1例免疫。
  • 绒毛膜绒毛取样组与无侵入性操作组免疫比例比较差异未达统计学显著(P=0.055)。

核心结论

  • 在未接受恒河猴预防的RhD阴性孕妇中,即使进行产前侵入性检测,孕25-29周前的RhD免疫率也非常低。

研究设计与样本

  • 基于丹麦登记数据的队列研究,纳入未接受恒河猴预防的RhD阴性孕妇共10085例。
  • 数据来自Rigshospitalet临床免疫学部门,并与丹麦胎儿医学数据库链接。
  • 按是否进行侵入性产前诊断操作分为无操作组(9353例)、羊膜腔穿刺组(189例)和绒毛膜绒毛取样组(543例)。

主要发现

  • 无操作组和羊膜腔穿刺组在孕8-12周与孕25-29周两次筛查间均无自发或操作导致的RhD免疫发生。
  • 绒毛膜绒毛取样组有1例发生RhD免疫。
  • 绒毛膜绒毛取样组与无侵入性检测组免疫比例比较差异未达统计学显著(P=0.055)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the risk of inducing RhD immunisation in pregnancies of RhD-negative mothers with an RhD-positive fetus undergoing chorionic villus samplings (CVS) or amniocenteses (AC). DESIGN, SETTING AND POPULATION: Registry-based study in a Danish cohort which has not been given rhesus prophylaxis. METHODS: Data were retrieved from the Department of Clinical Immunology at Rigshospitalet. All RhD-negative women carrying an RhD-positive fetus with screen test results from weeks 8-12 and weeks 25-29 were linked to data from the Danish Fetal Medicine Database. Data were divided into cases where no invasive prenatal diagnostic procedure was performed, cases that had AC performed, and cases that had CVS performed. MAIN OUTCOME MEASURES: A comparison of the proportion of women who developed RhD immunisation between the two screen tests. RESULTS: The cohort consisted of 10 085 women: 9353 had no invasive procedures performed, 189 had AC and 543 had CVS performed. No women were immunised spontaneously or due to the procedure between the first and second screen test in the group with no procedure performed, or in the AC group. One woman was immunised in the CVS group. When comparing the proportion of women who was immunised in the CVS group with the no invasive test group a non-significant difference was found (P = 0.055). CONCLUSION: The RhD immunisation rate before gestational weeks 25-29 in RhD-negative women carrying an RhD-positive fetus is very low, even in women undergoing prenatal invasive testing without rhesus prophylaxis. TWEETABLE ABSTRACT: The RhD immunisation rate during pregnancy is very low even in women undergoing prenatal invasive testing.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Kristensen SS, Nørgaard LN, Tabor A, et al. Do chorionic villus samplings (CVS) or amniocenteses (AC) induce RhD immunisation? An evaluation of a large Danish cohort with no routine administration of anti-D after invasive prenatal testing. BJOG. 2019. PMID: 31283084. doi:10.1111/1471-0528.15861

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。